Skip to product information
1 of 1
New Year Badge
🏷️ Save up to 70% on all books, discount auto applied

Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider

Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider

Regular price $27.00 USD
Regular price $119.00 USD Sale price $27.00 USD
Sale Sold out
Girl in a jacket

Instant Download

Your unique download link appears right after you complete your purchase, and is also sent instantly to the email address you provided.

ISBN

9783030520205

Authors

Publisher

Springer

Published Date

2020

Language

‎English

Page Count

1293

Size

byEdouard J. Trabulsi(Editor), Costas D. Lallas(Editor), Anne E. Lizardi-Calvaresi(Editor)&0more This book is designed to familiarize clinical practitioners in systemic therapy options and medical management of urologic malignancies including prostate cancer, bladder and upper tract urothelial carcinoma, and renal cell carcinoma. Organized by organ system, the text highlights new therapies such as novel forms of androgen deprivation, cytotoxic chemotherapy, immune check point and immunomodulatory agents, and targeted therapies. Written by experts in the field, the book also reviews current chemotherapy and immunotherapy regimens for genitourinary malignancies and discusses indications, outcomes, and toxicities, as well as clinical trial concepts. Each of the book’s chapters offers a bulleted box of clinical pearls on the particular role of the APP. Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider is a resource for urologists, uro-radiologists, medical clinicians and family practitioners alike, familiarizing its audiences with systemic therapy regimens for urologic malignancies, as well as their expected outcomes and side effects. Product Details Item Weight:1.1 pounds Paperback:324 pages ISBN-13:978-3030520205 Product dimensions:6.1 x 0.77 x 9.25 inches Publisher:Springer; 1st ed. 2021 edition (September 29, 2020) Language::English

View full details